From at-risk to recognition: improving detection of MASH

Chairs: Lise Lotte Gluud (DNK), Harpreet Bajaj (CAN)

17:00 – 17:17Spotlight on MASH: navigating early detection in the clinic​Lise Lotte Gluud (DNK)
Harpreet Bajaj (CAN)
17:17 – 17:27Enabling action in real-world care: audience Q&ALise Lotte Gluud (DNK)
Harpreet Bajaj (CAN)
17:27 – 17:30Final reflections and key takeawaysLise Lotte Gluud (DNK)
Harpreet Bajaj (CAN)
Novo Nordisk logo